Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
600
Trial Sponsor
Clinical Trial Start Date
May 9, 2019
0Primary Completion Date
October 21, 2020
0Study Completion Date
October 21, 2020
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Prevention0
Intervention Type
Drug0
Device0
Intervention Name
Placebo0
CELLECTRA® 20000
INO-45000
Interventional Trial Phase
Phase 10
Participating Facility
Official Name
Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers0
Last Updated
November 23, 2020
0Allocation Type
Randomized0
Intervention Model
Sequential Assignment0
Masking Type
Triple0
Masked Party
Investigator0
Care Provider0
Participant0
Study summary
This is a randomized and double-blinded within study group, placebo-controlled trial to evaluate the safety, tolerability and immunological profile of INO-4500 administered by intradermal (ID) injection followed by electroporation using the CELLECTRA® 2000 device in healthy adult volunteers.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
